As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of VolitionRx Limited. The largest reported stake is Lagoda Investment Management, L.P.'s, at 5.9%. 9 filings are on record since August 14, 2025 (Schedule 13D/A, September 16, 2026).
Sell to companies like VolitionRx Limited? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Lagoda Investment Management, L.P. · Sole voting: 0 · Shared voting: 1,650,505 · Sole dispositive: 0 · Shared dispositive: 1,650,505 · SCHEDULE 13D/A, 2026-09-16
- · Holder: Lagoda Investment Management, L.P. · Percent: 7.4% · SCHEDULE 13D
- · Holder: Lagoda Investment Management, L.P. · Percent: 14% · SCHEDULE 13G/A
- · Holder: Lagoda Investment Management, L.P. · Percent: 10.7% · SCHEDULE 13G/A
- · Holder: Armistice Capital, LLC · Percent: 4.99% · SCHEDULE 13G/A
VolitionRx Limited has 9 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 5.9% | 1,650,505 | SCHEDULE 13D/A, 2026-09-16 | 2026-09-15 |
| Armistice Capital, LLC | 4.99% | 6,449,635 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
Holding shares or following this stake? See who's behind VolitionRx Limited and the warning signs.
Free to see. No signup.
Keep reading
More on VolitionRx Limited and the records around it.
VolitionRx Limited elsewhere on the record
- Company profile and every filing Jan 2026
- Form D filing May 2025
- Who owns it
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch VolitionRx Limited
Get an email when VolitionRx Limited files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on VolitionRx Limited?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on VolitionRx Limited: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on VolitionRx Limited covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 0 | 1,650,505 | 0 | 1,650,505 | SCHEDULE 13D/A, 2026-09-16 |
| Lagoda Investment Management, LLC | 0 | 1,650,505 | 0 | 1,650,505 | SCHEDULE 13D/A, 2026-09-16 |
| Fatima Dickey | 0 | 1,650,505 | 0 | 1,650,505 | SCHEDULE 13D/A, 2026-09-16 |
The latest filing identifies VolitionRx Limited by CUSIP 928661206 and gives its principal executive office as 1489 West Warm Springs Road, Suite 110, Henderson, NV 89014 (SCHEDULE 13D/A, 2026-09-16).
Source of funds (Item 3)
Not amended.Lagoda Investment Management, L.P., SCHEDULE 13D/A, 2026-09-16
Purpose of Transaction (Item 4)
Lagoda Investment Management, L.P.
Not amended.Item 4 of the SCHEDULE 13D/A filed 2026-09-16
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Armistice Capital, LLC | 9.99% | SCHEDULE 13G/A |
| 2025-08-14 | Lagoda Investment Management, L.P. | 11.3% | SCHEDULE 13G/A |
| 2025-11-14 | Armistice Capital, LLC | 8.72% | SCHEDULE 13G/A |
| 2026-02-17 | Armistice Capital, LLC | 4.99% | SCHEDULE 13G/A |
| 2026-02-17 | Lagoda Investment Management, L.P. | 10.1% | SCHEDULE 13G/A |
| 2026-05-15 | Lagoda Investment Management, L.P. | 10.7% | SCHEDULE 13G/A |
| 2026-08-14 | Lagoda Investment Management, L.P. | 14% | SCHEDULE 13G/A |
| 2026-09-04 | Lagoda Investment Management, L.P. | 7.4% | SCHEDULE 13D |
| 2026-09-16 | Lagoda Investment Management, L.P. | 5.9% | SCHEDULE 13D/A |
Questions about who owns VolitionRx Limited
Who owns VolitionRx Limited?
On this page, one holder's latest ownership filing reports 5% or more of VolitionRx Limited: Lagoda Investment Management, L.P. (5.9%, Schedule 13D/A, filed 2026-09-16).
When did Lagoda Investment Management, L.P. buy into VolitionRx Limited?
The filings give report dates, not purchase dates. The earliest filing from Lagoda Investment Management, L.P. on this page is the Schedule 13G/A, filed 2025-08-14, reporting 11.3%; its latest, Schedule 13D/A filed 2026-09-16, reports 5.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for VolitionRx Limited
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 30, 2025 | Form D, private offering | $16.25M sold | Form D page | Source |
VolitionRx Limited: every filing and event
Tools for this story
Each opens in a new tab, filled in for VolitionRx Limited. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.